RNXT
insider transactionsRenovoRx, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 3 different insiders made open-market purchases in the last 365 days, totalling $38.3K.
Net shares · 365d
+227.2K
227.2K buy · 0 sell
Net value · 365d
$38.3K
$38.3K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
8
227.2K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Mark Voll KEY
Chief Financial Officer
$19.7K
25.0K sh · $0.79
Own +21%
-
Grant·A
Mark Voll KEY
Chief Financial Officer
$0
80.0K sh
Own +214%
-
Grant·A
Chief Clinical Officer
$0
128.6K sh
Own New
-
Grant·A
Shaun Bagai KEY
Chief Executive Officer
$0
946.1K sh
Own New
-
Grant·A
Chief Medical Officer
$0
621.7K sh
Own New
-
Grant·A
Mark Voll KEY
Chief Financial Officer
$0
12.4K sh
Own +50%
-
Buy·P
Mark Voll KEY
Chief Financial Officer
—
48.6K sh
Own New
-
Buy·P
Mark Voll KEY
Chief Financial Officer
—
97.2K sh
Own New
-
Buy·P
Shaun Bagai KEY
Chief Executive Officer
—
12.2K sh
Own New
-
Buy·P
Shaun Bagai KEY
Chief Executive Officer
—
24.3K sh
Own +8%
-
Buy·P
Chief Medical Officer
$10.0K
10.0K sh · $1.00
Own +1%
-
Buy·P
Chief Medical Officer
$8.4K
9.8K sh · $0.86
Own +1%
-
Buy·P
Chief Medical Officer
$169
205 sh · $0.83
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 19, 2026 | Mark Voll KEY | Buy P | 25.0K | $19.7K |
| Apr 3, 2026 | Mark Voll KEY | Grant A | 80.0K | $0 |
| Apr 3, 2026 | Leesa Gentry | Grant A | 128.6K | $0 |
| Apr 3, 2026 | Shaun Bagai KEY | Grant A | 946.1K | $0 |
| Apr 3, 2026 | Ramtin Agah | Grant A | 621.7K | $0 |
| Mar 25, 2026 | Mark Voll KEY | Grant A | 12.4K | $0 |
| Mar 20, 2026 | Mark Voll KEY | Buy P | 48.6K | — |
| Mar 20, 2026 | Mark Voll KEY | Buy P | 97.2K | — |
| Mar 20, 2026 | Shaun Bagai KEY | Buy P | 12.2K | — |
| Mar 20, 2026 | Shaun Bagai KEY | Buy P | 24.3K | — |
| Jan 21, 2026 | Ramtin Agah | Buy P | 10.0K | $10.0K |
| Dec 31, 2025 | Ramtin Agah | Buy P | 9.8K | $8.4K |
| Dec 30, 2025 | Ramtin Agah | Buy P | 205 | $169 |
About RNXT insider trading
This page tracks insider transactions for RenovoRx, Inc. (RNXT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.